The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort

Abstract Background Serum fibroblast growth factor 23 (FGF-23) levels are markedly elevated in haemodialysis patients and have been linked to mortality outcomes. Small studies in health and chronic kidney disease, have demonstrated marked intra- and inter-individual variability in measured FGF-23 le...

Full description

Bibliographic Details
Main Authors: Matthew J. Damasiewicz, Zhong X. Lu, Peter G. Kerr, Kevan R. Polkinghorne
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Nephrology
Subjects:
FGF-23
CKD-MBD
Haemodialysis
Phosphate
Online Access:http://link.springer.com/article/10.1186/s12882-018-1127-7

Internet

http://link.springer.com/article/10.1186/s12882-018-1127-7

Similar Items